Personalized immune cells tested as new weapon against lung cancer
Disease control
Completed
This early-stage study tested whether a personalized immune cell therapy called PB101 is safe when given alongside standard lung cancer drugs. Researchers collected immune cells from 8 patients with advanced EGFR-mutated lung cancer, grew them in a lab, and infused them back to h…
Phase: PHASE1 • Sponsor: Precision Biotech Taiwan Corp. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC